BIOMARIN PHARMACEUTICAL INC - FORM 10-K - EX-23.2 - CONSENT OF PRICEWATERHOUSECOOPERS, LLP - February 26, 2010

Attached files

file filename
10-K - FORM 10-K - BIOMARIN PHARMACEUTICAL INCd10k.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 - BIOMARIN PHARMACEUTICAL INCdex311.htm
EX-32.1 - CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 - BIOMARIN PHARMACEUTICAL INCdex321.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 - BIOMARIN PHARMACEUTICAL INCdex312.htm
EX-23.1 - CONSENT OF KPMG LLP - BIOMARIN PHARMACEUTICAL INCdex231.htm
EX-10.37 - STOCK PURCHASE AGREEMENT - BIOMARIN PHARMACEUTICAL INCdex1037.htm
EX-21.1 - SUBSIDIARIES OF BIOMARIN PHARMACEUTICAL INC. - BIOMARIN PHARMACEUTICAL INCdex211.htm
EX-99.1 - BIOMARIN/GENZYME LLC CONSOLIDATED FINANCIAL STATEMENTS - BIOMARIN PHARMACEUTICAL INCdex991.htm

Exhibit 23.2

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-136963, 333-85368, 333-84787) of BioMarin Pharmaceutical Inc. of our report dated February 25, 2008 relating to the financial statement of BioMarin/Genzyme LLC, which appears in this Form 10-K.

 

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts

    February 24, 2010

Stock widget

Investing forum

BIOMARIN PHARMACEUTICAL INC Reports

Also read